Dong, Y.; Zhou, H.; Alhaskawi, A.; Wang, Z.; Lai, J.; Yao, C.; Liu, Z.; Hasan Abdullah Ezzi, S.; Goutham Kota, V.; Hasan Abdulla Hasan Abdulla, M.;
et al. The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies. Cancers 2023, 15, 1193.
https://doi.org/10.3390/cancers15041193
AMA Style
Dong Y, Zhou H, Alhaskawi A, Wang Z, Lai J, Yao C, Liu Z, Hasan Abdullah Ezzi S, Goutham Kota V, Hasan Abdulla Hasan Abdulla M,
et al. The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies. Cancers. 2023; 15(4):1193.
https://doi.org/10.3390/cancers15041193
Chicago/Turabian Style
Dong, Yanzhao, Haiying Zhou, Ahmad Alhaskawi, Zewei Wang, Jingtian Lai, Chengjun Yao, Zhenfeng Liu, Sohaib Hasan Abdullah Ezzi, Vishnu Goutham Kota, Mohamed Hasan Abdulla Hasan Abdulla,
and et al. 2023. "The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies" Cancers 15, no. 4: 1193.
https://doi.org/10.3390/cancers15041193
APA Style
Dong, Y., Zhou, H., Alhaskawi, A., Wang, Z., Lai, J., Yao, C., Liu, Z., Hasan Abdullah Ezzi, S., Goutham Kota, V., Hasan Abdulla Hasan Abdulla, M., & Lu, H.
(2023). The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies. Cancers, 15(4), 1193.
https://doi.org/10.3390/cancers15041193